Abstract

Microneedle technologies have the potential for expanding the capabilities of wearable health monitoring from physiology to biochemistry. This paper presents the fabrication of silicon hollow microneedles by a deep-reactive ion etching (DRIE) process, with the aim of exploring the feasibility of microneedle-based in-vivo monitoring of biomarkers in skin fluid. Such devices shall have the ability to allow the sensing elements to be integrated either within the needle borehole or on the backside of the device, relying on capillary filling of the borehole with dermal interstitial fluid (ISF) for transporting clinically relevant biomarkers to the sensor sites. The modified DRIE process was utilized for the anisotropic etching of circular holes with diameters as small as 30 μm to a depth of >300 μm by enhancing ion bombardment to efficiently remove the fluorocarbon passivation polymer. Afterward, isotropic wet and/or dry etching was utilized to sharpen the needle due to faster etching at the pillar top, achieving tip radii as small as 5 μm. Such sharp microneedles have been demonstrated to be sufficiently robust to penetrate porcine skin without needing any aids such as an impact-insertion applicator, with the needles remaining mechanically intact after repetitive penetrations. The capillary filling of DRIE-etched through-wafer holes with water has also been demonstrated, showing the feasibility of use to transport the analyte to the target sites.

Highlights

  • Wearable healthcare monitoring technologies have the potential for dramatically expanding the capability of data acquisition regarding an individual’s health[1,2]

  • This paper presents the deep-reactive ion etching (DRIE) of silicon hollow microneedles, which resemble elongated cones with smooth tapering from the shank to extreme sharpness

  • The pillar base decreased to 55 μm, creating a reentrant profile as a result of aspect ratio-dependent etching (ARDE) on large open areas[51]

Read more

Summary

Introduction

Wearable healthcare monitoring technologies have the potential for dramatically expanding the capability of data acquisition regarding an individual’s health[1,2]. Microneedle technologies have become increasingly interesting for unleashing the potential to minimally invasively interfere with an individual’s biochemistry, such as for drug delivery[3,4], interstitial fluid sampling[5,6], and diagnostics[7,8]. Microneedles require only a small area of skin to be penetrated at a limited depth, resulting in Silicon microneedles are desirable due to their excellent biocompatibility and, in particular, mechanical properties superior to those of polymer and metal, such as a nonductile nature, high Young’s Modulus, and indentation hardness enabling skin penetration without breakage in the skin[9]. Comprehensive studies of the immunohistochemistry of brain tissues demonstrated that silicon devices and the byproducts of their dissolution in the intracranial space are biocompatible[11,12]. The Food and Drug Administration (FDA) has granted clearance for silicon devices, such as silicon microneedles

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call